To view the PDF file, sign up for a MySharenet subscription.

JSE LIMITED - Index Change Advice - Aspen Pharmacare Holdings Free Float Update

Release Date: 21/11/2013 17:03
Code(s): JSER     PDF:  
Wrap Text
Index Change Advice - Aspen Pharmacare Holdings Free Float Update

  Aspen Pharmacare Holdings (South Africa): Investability Weight

                           Change

                FTSE/JSE Africa Index Series



                                21 November 2013

Following the completion of a secondary offering and receipt of updated shareholder

information for Aspen Pharmacare Holdings (South Africa, constituent), FTSE and the

JSE announces the following changes:



           INDEX                           CHANGE                 EFFECTIVE FROM

                                                                     START OF

                                                                     TRADING



FTSE/JSE Africa Top 40         Aspen Pharmacare Holdings         29th November

(J200)                         (South Africa, ZAE000066692,      2013

                               B09C0Z1) will remain in the index

                               with an unchanged shares in

                               issue total of 454,779,457 and an

                               increased investability weighting

                               of 67%.



FTSE/JSE Africa All Share      Aspen Pharmacare Holdings will    29th November

(J203)                         be treated as above.              2013



FTSE/JSE Equally Weighted      Aspen Pharmacare Holdings will    29th November

Top 40 Index (J2EQ)            be treated as above.              2013



FTSE/JSE Equally Weighted      Aspen Pharmacare Holdings will    29th November

Industrial 25 Index (J5EQ)     be treated as above.              2013



FTSE/JSE Africa Industrial 25 Aspen Pharmacare Holdings will     29th November

(J211)                        be treated as above.               2013



FTSE/JSE Africa Financial &    Aspen Pharmacare Holdings will    29th November

Industrial 30 (J213)           be treated as above.              2013



FTSE JSE RAFI All Share        Aspen Pharmacare Holdings will    29th November

Index (J263)                   be treated as above.              2013



FTSE JSE RAFI All Share        Aspen Pharmacare Holdings will    29th November

Capped Index (J283)            be treated as above.              2013



FTSE/JSE Africa Capped Top     Aspen Pharmacare Holdings will    29th November

40 (J300)                      be treated as above.              2013



FTSE/JSE Africa Capped All     Aspen Pharmacare Holdings will    29th November

Share (J303)                   be treated as above.              2013

 FTSE/JSE Africa Shareholder              Aspen Pharmacare Holdings will             29th November

 Weighted Top 40 (J400)                   be treated as above.                       2013



 FTSE/JSE Africa Shareholder              Aspen Pharmacare Holdings will             29th November

 Weighted All Share (J403)                be treated as above.                       2013



 FTSE/JSE Africa Style (J330              Aspen Pharmacare Holdings will             29th November

 and J331)                                be treated as above.                       2013



 FTSE/JSE Shariah Top 40                  Aspen Pharmacare Holdings will             29th November

 Index (J140)                             be treated as above.                       2013



 FTSE/JSE Capped Shariah                  Aspen Pharmacare Holdings will             29th November

 Top 40 Index (J141)                      be treated as above.                       2013



 FTSE/JSE Africa All Share                Aspen Pharmacare Holdings will             29th November

 Shariah (J143)                           be treated as above.                       2013





For further information or general enquiries please contact us at info@ftse.com or indices@jse.co.za or call:





Client Services   in   UK:                           Tel: +44 (0) 20 7866 1810

Client Services   in   Europe, Middle East & Africa: Tel: +44 (0) 20 7866 1810

Client Services   in   US:                           Tel: +1 888 747 FTSE (3873) or +1 212 314 1139

Client Services   in   Asia Pacific:                 Tel: +852 2164 3333 or +65 6223 3738 or +81 3 3581 2811

JSE Limited:                                         Tel: +27 11 520 7137





Alternatively please visit our website at www.ftse.com or www.ftsejse.co.za





                                       Terms of Use | Copyright © FTSE


Date: 21/11/2013 05:03:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story